Building Resiliency Among Caregivers of Curvivors and Metavivors: A Pilot randomized Trial

建立幸存者和元幸存者的照顾者的复原力:一项随机试点试验

基本信息

  • 批准号:
    10509455
  • 负责人:
  • 金额:
    $ 43.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-19 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

There is a large and growing population of caregivers (partner/family member/friend) for cancer survivors who have completed curative intent therapy (“curvivors”) and for those who live for many years with metastatic disease (“metavivors”). The emotional distress that caregivers experience is universal, irrespective of their loved one’s diagnosis, stage, treatment, or illness trajectory. Caregivers of both curvivors and metavivors face similar ongoing stressors (e.g., such as fear of cancer recurrence/progression, treatment toxicities and late effects, and difficulty adapting to life changes after cancer) and struggle with elevated distress. There is increasing recognition of reciprocal dynamics between caregiver and survivor distress, underscoring the importance of addressing the psychological, physical, and healthcare utilization needs of both in order to improve health outcomes. Caregivers play a critical role to ensure that survivors adhere to recommended follow-up care as well as attend to their own healthcare needs. While the needs of cancer survivors and their caregivers are well described, there are no interventions specifically focusing on the needs of caregivers of curvivors and metavivors; interventions have focused on caregiving at the end of life and not the chronic, ongoing stress of post-treatment transitions and living with cancer. Furthermore, caregiver interventions have not focused on promoting resiliency skills as a strategy to enhance post-traumatic growth and caregivers’ capacity to manage chronic stress and distress. Our team has developed an evidence-based mind-body group resiliency intervention, the Stress Management and Resiliency Training-Relaxation Response Program (SMART-3RP) and has demonstrated its efficacy for improving resiliency and reducing distress in patients with chronic medical conditions and healthcare clinicians. We propose to conduct a pilot randomized trial of the SMART 3RP vs. enhanced usual care. The population is 48 caregivers and cancer survivor dyads at the Massachusetts General Hospital Cancer Center. We propose to intervene simultaneously, yet focus separately, on improving the resiliency of caregivers and survivors. We will determine the feasibility and acceptability of a SMART-3RP for cancer caregivers and survivors; determine the preliminary efficacy of the SMART-3RP for improving resiliency in caregivers and survivors; and explore effects of SMART-3RP on caregivers’ and survivors’ health care utilization. Our multidisciplinary team has extensive experience in conducting survivor and caregiver outcome research, developing and testing biobehavioral and e-Health interventions, and examining healthcare system utilization. If proven effective, this virtual intervention can be tested in an effectiveness-implementation trial to improve the experience and quality of care for millions of caregivers and cancer survivors.
为癌症幸存者提供照顾者(伴侣/家人/朋友)的人数很大,而且还在不断增长 已经完成了治疗意图治疗(“Curvivors”)和那些生活了多年的转移性肿瘤患者 疾病(“变食者”)。照顾者经历的情绪痛苦是普遍的,无论他们 所爱的人的诊断、阶段、治疗或疾病轨迹。Curvivors和Metavivors的照顾者面对 类似的持续应激源(例如,对癌症复发/进展的恐惧、治疗毒性和晚期 癌症影响和难以适应癌症后的生活变化),并与更高的痛苦作斗争。的确有 越来越多的人认识到照顾者和幸存者之间的相互作用,强调了 满足两者的心理、身体和医疗保健利用需求的重要性 改善健康状况。护理员在确保幸存者遵守建议的 后续护理以及照顾自己的医疗保健需求。虽然癌症幸存者和他们的需求 照顾者被很好地描述,没有专门关注照顾者需求的干预措施 康复者和变性者;干预措施侧重于生命末期的护理,而不是慢性病患者, 持续的治疗后过渡和癌症生活的压力。此外,护理者的干预措施 没有将促进复原力技能作为促进创伤后成长和照顾者的战略的重点 管理长期压力和痛苦的能力。我们的团队已经开发了一个基于证据的心身小组 弹性干预、压力管理和弹性训练-放松反应计划 (SMART-3RP),并已证明其在提高恢复力和减少患者痛苦方面的疗效 慢性疾病和保健临床医生。我们建议进行一项试点随机试验, 智能3RP与增强的日常护理。人口中有48名照顾者和癌症幸存者二人 马萨诸塞州总医院癌症中心。我们建议同时进行干预,但重点是 另外,关于提高照顾者和幸存者的复原力。我们将确定可行性和 SMART-3RP对癌症护理人员和幸存者的可接受性;确定该药物的初步疗效 SMART-3RP用于提高照顾者和幸存者的复原力;并探讨SMART-3RP对 照顾者和幸存者的卫生保健利用情况。我们的多学科团队在以下方面拥有丰富的经验 开展幸存者和照顾者成果研究,开发和测试生物行为和电子健康 干预措施,并检查医疗保健系统的利用率。如果被证明有效,这种虚拟干预可以 在有效性实施试验中进行了测试,以改善数百万人的护理体验和质量 照顾者和癌症幸存者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Areej El-Jawahri其他文献

Areej El-Jawahri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Areej El-Jawahri', 18)}}的其他基金

Examining Gender as a Sociocultural Variable Shaping Health Outcomes of Cancer Caregiving
检查性别作为影响癌症护理健康结果的社会文化变量
  • 批准号:
    10770121
  • 财政年份:
    2022
  • 资助金额:
    $ 43.2万
  • 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
  • 批准号:
    10028263
  • 财政年份:
    2020
  • 资助金额:
    $ 43.2万
  • 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
  • 批准号:
    10636846
  • 财政年份:
    2020
  • 资助金额:
    $ 43.2万
  • 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
  • 批准号:
    10252907
  • 财政年份:
    2020
  • 资助金额:
    $ 43.2万
  • 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
  • 批准号:
    10412118
  • 财政年份:
    2020
  • 资助金额:
    $ 43.2万
  • 项目类别:
Multimodal Mobile Intervention Application (app) to Address Symptoms in Hematopoietic Stem Cell Transplant Survivors
用于解决造血干细胞移植幸存者症状的多模式移动干预应用程序 (app)
  • 批准号:
    10000145
  • 财政年份:
    2019
  • 资助金额:
    $ 43.2万
  • 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
  • 批准号:
    9980805
  • 财政年份:
    2018
  • 资助金额:
    $ 43.2万
  • 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
  • 批准号:
    10456762
  • 财政年份:
    2018
  • 资助金额:
    $ 43.2万
  • 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
  • 批准号:
    10222595
  • 财政年份:
    2018
  • 资助金额:
    $ 43.2万
  • 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
  • 批准号:
    9761504
  • 财政年份:
    2018
  • 资助金额:
    $ 43.2万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 43.2万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了